Newsroom

LONDON--(BUSINESS WIRE)--  Re: LLOYDS BANK CORPORATE MARKETS PLC USD 32,000,000.00 MATURING: 28-Sep-2026 ISIN: XS2695405915 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 29-Sep-2025 TO 29-Dec-2025 HAS BEEN FIXED AT 5.18 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 29-Dec-2025 WILL AMOUNT TO: USD 2,617.55 PER USD 200,000.00 DENOMINATION  ...

NEWTON, Mass. e PETACH TIKVA, Israele--(BUSINESS WIRE)--CyberArk (NASDAQ: CYBR), azienda leader globale nella sicurezza dell'identità, oggi ha annunciato di essere stata riconosciuta come Leader in IDC MarketScape: Worldwide Integrated Solutions for Identity Security 2025 (Soluzioni integrate globali per la sicurezza dell'identità 2025) Valutazione dei fornitori. CyberArk estende i controlli dinamici dei privilegi in tutti i tipi di identità con la sua piattaforma unificata, consentendo alle or...

LONDON--(BUSINESS WIRE)--  Re: LLOYDS BANK CORPORATE MARKETS PLC USD 30,000,000.00 MATURING: 29-Sep-2026 ISIN: XS2697682826 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 29-Sep-2025 TO 29-Dec-2025 HAS BEEN FIXED AT 5.18 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 29-Dec-2025 WILL AMOUNT TO: USD 2,617.55 PER USD 200,000.00 DENOMINATION  ...

LONDON--(BUSINESS WIRE)--  19-December-2025 Issue: Mitsubishi HC Capital UK Plc Series 825 XS2689105067 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 26-September-2025 Date To: 29-December-2025 Record Date: 26-December-2025 Value Date: 29-December-2025 Benchmark Rate: 4.06157% Margin: 1.2% Total Rate: 5.26157% Floor: 0% Number of Days: 94 Day Count: Actual / 360 Interest Frequency: Quarterly Total Amou...

LONDON--(BUSINESS WIRE)--  18-December-2025 Issue: Coventry Building Society, CB Series 3 XS2346562874 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 26-November-2025 Date To: 29-December-2025 Record Date: 26-December-2025 Value Date: 29-December-2025 Benchmark Rate: 3.9788% Margin: 0.4% Total Rate: 4.3788% Floor: 0% Number of Days: 33 Day Count: Actual / 365 (Fixed) Interest Frequency: Monthly Denomina...

NEW YORK--(BUSINESS WIRE)--Deutsche Bank announced today its appointment as depositary bank for the American Depositary Receipt program of Metaplanet Inc. Metaplanet Inc. (OTC: MPJPY) is a Japanese Bitcoin treasury company. The company leverages Bitcoin as its core treasury reserve asset, employing capital market strategies to accumulate BTC through equity and fixed income offerings while building complementary Bitcoin-focused business lines.* In addition to specializing in administering cross-...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inspirato Incorporated (NasdaqGM: ISPO) to Exclusive Investments LLC. Under the terms of the proposed transaction, shareholders of Inspirato will receive $4.27 in cash for each share of Inspirato that they own. KSF is seeking to determine whether this consideration and the process that led to it are...

西雅图--(BUSINESS WIRE)--(美国商业资讯)-- 可扩展且易于获取的单细胞测序解决方案的领先提供商Parse Biosciences今日宣布与Codebreaker Labs达成合作，双方将联合开发并验证一款突破性平台。该平台可同时检测数千种基因变异，并在单细胞分辨率下测量变异产生的影响。通过结合Codebreaker的合成生物学平台和变异工程能力，以及Parse的Evercode™技术的规模化优势与易获取特性，本次合作旨在生成AI开发者、药物研发团队和临床研究人员日益寻求的因果关系数据。 当前的基因组学研究严重依赖观测数据，也就是在大规模人群中出现的变异。但罕见变异和个体特异性变异（这类变异往往仅出现在单一个体或单个家族中）几乎无法通过这种方式开展研究，原因在于携带此类变异的个体数量过少，无法得出具备统计学意义的结论。这就导致即便是基于观测数据集训练出的最先进模型，也会在这类罕见变异的研究中存在盲区。 这款全新平台通过规模化构建变异模型、测量变异在人类细胞中产生的影响，攻克了上述局限性，能够生成观测数据集无法提供的因果标注信息。同时，该平台结合高通量单细胞检测技术，确...

LONDON--(BUSINESS WIRE)--  Re: ORBITA FUNDING 2023-1 PLC GBP 326,642,000.00 MATURING: 22-Oct-2030 ISIN: XS2699151028 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 24-Nov-2025 TO 22-Dec-2025 HAS BEEN FIXED AT 4.83 PCT DAY BASIS: ACTUAL/365(FIX) INTEREST PAYABLE VALUE 22-Dec-2025 WILL AMOUNT TO: GBP 970,934.30 PER GBP 262,208,868.33 DENOMINATION  ...

西雅圖--(BUSINESS WIRE)--(美國商業資訊)-- 可擴充且易於取得的單細胞定序解決方案的領導廠商Parse Biosciences今日宣布與Codebreaker Labs達成合作，雙方將共同開發並驗證一款突破性平台。該平台可同時檢測數千種基因變異，並在單細胞解析度下測量變異產生的影響。透過結合Codebreaker的合成生物學平台和變異工程能力，以及Parse的Evercode™技術的規模化優勢與易取得特性，本次合作旨在生成AI開發者、藥物研發團隊和臨床研究人員日益尋求的因果關係資料。 目前的基因組學研究嚴重依賴觀測資料，也就是在大規模人群中出現的變異。但罕見變異和個體特異性變異（這類變異往往僅出現在單一個體或單個家族中）幾乎無法透過這種方式展開研究，原因在於攜帶此類變異的個體數量過少，無法得出具備統計學意義的結論。這就導致即便是以觀測資料集為基礎訓練出的最先進模型，也會在這類罕見變異的研究中存在盲區。 這款全新平台透過規模化建構變異模型、測量變異在人類細胞中產生的影響，攻克了上述局限性，能夠生成觀測資料集無法提供的因果標籤。同時，該平台結合高通量單細胞檢測技術，確保...